C-C Chemokine Receptor 7 in Cancer

Cells. 2022 Feb 14;11(4):656. doi: 10.3390/cells11040656.

Abstract

C-C chemokine receptor 7 (CCR7) was one of the first two chemokine receptors that were found to be upregulated in breast cancers. Chemokine receptors promote chemotaxis of cells and tissue organization. Since under homeostatic conditions, CCR7 promotes migration of immune cells to lymph nodes, questions immediately arose regarding the ability of CCR7 to direct migration of cancer cells to lymph nodes. The literature since 2000 was examined to determine to what extent the expression of CCR7 in malignant tumors promoted migration to the lymph nodes. The data indicated that in different cancers, CCR7 plays distinct roles in directing cells to lymph nodes, the skin or to the central nervous system. In certain tumors, it may even serve a protective role. Future studies should focus on defining mechanisms that differentially regulate the unfavorable or beneficial role that CCR7 plays in cancer pathophysiology, to be able to improve outcomes in patients who harbor CCR7-positive cancers.

Keywords: C-C chemokine receptor 7; cancer; metastases; survival.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Breast Neoplasms* / pathology
  • Chemokines, CC* / metabolism
  • Chemotaxis
  • Female
  • Humans
  • Lymph Nodes / pathology
  • Receptors, CCR7* / genetics
  • Receptors, CCR7* / metabolism

Substances

  • CCR7 protein, human
  • Chemokines, CC
  • Receptors, CCR7